Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic anti-CD38 DAR-T cells STI-1492

A preparation of human allogeneic T lymphocytes that are gene-edited with the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 nuclease complex to disrupt the expression of endogenous T-cell receptor (TCR) alpha and to express a dimeric antigen receptor (DAR) composed of a fragment antigen-binding variable region (Fab) recognizing the tumor-associated antigen (TAA) cluster of differentiation 38 (CD38), linked to the intracellular signaling domains of 4-1BB (CD137) and the zeta chain of the TCR/CD3 complex (TCRzeta; CD247; CD3zeta), with potential immunomodulating and antineoplastic activities. Upon intravenous administration, allogeneic anti-CD38 DAR-T cells STI-1492 are directed to and induce selective toxicity in CD38-expressing tumor cells. CD38, a type II transmembrane glycoprotein, is present on various immune cells and hematologic malignancies, and its expression has been correlated with poor prognosis. The disruption of endogenous TCR alpha prevents graft-versus-host disease (GvHD).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic anti-CD38 A2 KOKI DAR T cells STI-1492
allogeneic anti-CD38 dimeric antigen receptor-expressing T lymphocytes STI-1492
allogeneic second generation anti-CD38 Knock-out knock-in dimeric antigen receptor-4-1BB-CD3zeta-expressing T cells STI-1492
anti-CD38 A2 KOKI DAR allogeneic T cells STI-1492
Code name:STI 1492
STI-1492
STI1492
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search